TETRAHIDROIZOHINOLINOVI compounds with antagonist activity with respect to dopamine receptors D1 and D2, METHOD OF PRODUCING THEM, THEIR PHARMACEUTICAL COMPOSITION BASED ON BINDING AND METHOD dopamine receptors D1 and D2
The invention relates to new tetrahydroisoquinoline compounds and to pharmaceutical compositions, methods of preparing the compositions and to use in analgesia and in the treatment of psychosis, Parkinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment, or in alleviating drug dependence or delayed dyskinesia.